Document Classification

Section Type: RESULTS

Text: In the sibutramine group, body weight was reduced from a mean (SD) of 73. 9 (10. 3) kg at baseline to 69. 8 (10. 6) kg at month 12 ; BMI decreased from 29. 9 (2. 6) to 28. 2 (2. 9) kg/M2 ; waist circumference was reduced from 94. 9 (8. 4) to 90. 8 (8. 4) cm ; the plasma fasting glucose concentration decreased from 140. 4 (29. 4) to 114. 2 (32. 0) mg/dL ; and the HbA1c value was reduced from 8. 9 % (1. 2) to 8. 3 % (1. 2) (all, P < 0. 001).